MIR4713

Across TCGA pan-cancer cohorts, MIR4713 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR4713 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR4713 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4713 expression acts as an unfavorable survival marker.

KICH, BRCA, and UCEC are the cancer types where MIR4713 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
BRCA	OS	Tertile	All	0.144	0.579	<.001	90	view →
UCEC	DFS	Tertile	All	0.100	0.648	.001	36	view →
LUSC	DFS	Tertile	II,III,IV	0.233	0.672	.036	15	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →
LUAD	OS	Tertile	All	0.591	0.837	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR4713–KICH (DFS)

Open the KICH breakdown →